BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33878040)

  • 21. Locally Aggressive Giant Cell Tumor of Bone With Pulmonary Distant Metastasis and Extrapulmonary Seeding in Pregnancy.
    Murshed KA; Elsayed AM; Szabados L; Rashid S; Ammar A
    J Am Acad Orthop Surg Glob Res Rev; 2020 Jan; 4(1):. PubMed ID: 32159067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary Malignancy in Giant Cell Tumor: A Single-Center Study.
    Joo MW; Lee YS; Park HS; Chung YG; Yoon C
    Curr Oncol; 2022 Jun; 29(6):4068-4080. PubMed ID: 35735433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple-phase dynamic MRI: a new clue to predict malignant transformation of giant cell tumor of bone.
    Chen L; Ding XY; Wang CS; Si MJ; Du LJ; Lu Y
    Eur J Radiol; 2014 Feb; 83(2):354-9. PubMed ID: 24239410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Giant cell tumor of bone and malignancies in giant cell tumor: a clinicopathologic analysis].
    Gong LH; Sun XQ; Meng SQ; Huang XY
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):312-5. PubMed ID: 19575873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.
    Yamamoto H; Iwasaki T; Yamada Y; Matsumoto Y; Otsuka H; Yoshimoto M; Kohashi K; Taguchi K; Yokoyama R; Nakashima Y; Oda Y
    Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New aspects on giant cell tumor of bone].
    Lüke J; Hasenfratz M; Möller P; Barth TFE
    Pathologe; 2018 Mar; 39(2):125-131. PubMed ID: 29110035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant transformation of a giant cell tumor 25 years after initial treatment.
    Mori Y; Tsuchiya H; Karita M; Nonomura A; Nojima T; Tomita K
    Clin Orthop Relat Res; 2000 Dec; (381):185-91. PubMed ID: 11127655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benign giant cell tumor of bone with osteosarcomatous transformation ("dedifferentiated" primary malignant GCT): report of two cases.
    Brien EW; Mirra JM; Kessler S; Suen M; Ho JK; Yang WT
    Skeletal Radiol; 1997 Apr; 26(4):246-55. PubMed ID: 9151375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoscopic Surgery of Giant Cell Tumor of Bone for Preservation of Proximal Fibula.
    Futani H; Kumanishi S; Minakawa GO; Yoshiya S
    Anticancer Res; 2018 May; 38(5):2995-3000. PubMed ID: 29715130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
    BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
    Sano K; Suehara Y; Okubo T; Sasa K; Kurihara T; Akaike K; Kubota D; Torigoe T; Hasegawa N; Ishii M; Nakamura Y; Kim Y; Takagi T; Kaneko K; Hayashi T; Saito T
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020929786. PubMed ID: 32539628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignancy in giant cell tumor of bone in the extremities.
    Liu W; Chan CM; Gong L; Bui MM; Han G; Letson GD; Yang Y; Niu X
    J Bone Oncol; 2021 Feb; 26():100334. PubMed ID: 33251099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.
    Yamamoto H; Ishihara S; Toda Y; Oda Y
    Med Mol Morphol; 2020 Mar; 53(1):1-6. PubMed ID: 31748824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinosarcomatous malignancy, osteosarcoma and squamous cell carcinoma, in giant cell tumor of the right distal femur.
    Machinami R; Nishida K; Ishida T; Matsumoto S; Kuroda K; Kobayashi M; Takeuchi K; Ishikawa Y
    Pathol Res Pract; 2008; 204(8):583-8. PubMed ID: 18440162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrosarcoma development 15 years after curettage and bone grafting of giant cell tumor of bone.
    Li J; Zhu Y; Wei Y
    Orthopedics; 2014 May; 37(5):e512-6. PubMed ID: 24810832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
    Kato I; Furuya M; Matsuo K; Kawabata Y; Tanaka R; Ohashi K
    Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological and clinical characteristics of malignant giant cell tumor of bone.
    Gong L; Liu W; Sun X; Sajdik C; Tian X; Niu X; Huang X
    Virchows Arch; 2012 Mar; 460(3):327-34. PubMed ID: 22350004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteosarcoma of the scaphoid. A case report and review of the literature.
    Marcuzzi A; Maiorana A; Adani R; Spina V; Busa R; Caroli A
    J Bone Joint Surg Br; 1996 Sep; 78(5):699-701. PubMed ID: 8836052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chondroblastoma-like primary malignant giant cell tumor of the humerus - a case report.
    Kinkor Z; Grossmann P; Špůrková Z; Věcková Z; Matějovský Z
    Cesk Patol; 2019; 55(1):42-47. PubMed ID: 30939886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.